Earnings · China A-shares
Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A (605199) earnings
Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A published its Q3 report on 2026-10-30: net profit -1197.95% year on year, -229.57% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +1.35% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -1197.95%
- Excl. one-offs YoY
- -229.57%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.77% | — |
| 3 days | +1.35% | — |
| 7 days | +4.82% | — |
| 14 days | -5.97% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 3 of 6 reports (average -2.40%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥145.55M | -1197.95% | — | -42.25% | -0.36 | -42.83% | +1.35% | — | — |
| 2026 interim report | 2026-08-27 | -¥113.39M | -4805.36% | — | -52.55% | -0.28 | -31.86% | -1.49% | -7.95% | +0.99% |
| 2026 Q1 report | 2026-04-29 | -¥28.96M | -218.94% | — | -56.61% | -0.07 | -7.27% | -5.21% | -7.53% | -8.47% |
| 2025 annual report | 2026-04-29 | -¥287.37M | -4.71% | +1.78% | -36.27% | -0.72 | -51.65% | -5.21% | -7.53% | -8.47% |
| 2025 Q3 report | 2025-10-31 | -¥11.21M | +90.46% | +71.29% | -33.88% | -0.03 | -1.61% | +4.43% | -2.00% | +2.69% |
| 2025 interim report | 2025-08-30 | ¥2.41M | -94.14% | — | -42.89% | 0.01 | 0.34% | +0.77% | -1.54% | -2.38% |
| 2025 Q1 report | 2025-04-29 | ¥24.35M | -11.23% | -28.05% | -28.42% | 0.06 | 3.42% | -14.24% | -29.17% | -31.75% |
| 2024 annual report | 2025-04-29 | -¥274.46M | -2629.23% | — | -21.26% | -0.69 | -31.66% | -14.24% | -29.17% | -31.75% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.